Biofourmis and Chugai Partner to Develop an Objective Assessment of Pain Using Digital Technology

Bangkok, July 21 2020 – Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) and Biofourmis, a Boston- based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment of pain associated with endometriosis.

 

Pain is one of the main symptoms of endometriosis and therapeutically important. The severity of pain may vary from day to day, and it can be a major issue that affects patients’ quality of life. However, because pain can be a subjective symptom, patients often have difficulty quantifying their level of pain when communicating with healthcare professionals and family members.

 

The partnership leverages Biofourmis’ Biovitals® platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and artificial intelligence (AI)-based algorithms. The solution will be validated in a global, multi-center observational study enrolling more than 120 endometriosis patients.

 

Biofourmis has demonstrated its ability to discover, develop and clinically validate multivariate digital biomarkers across multiple therapeutic areas. The digital solution for managing patients with endometriosis in an ambulatory setting will include a wearable, clinical-grade biosensor to capture physiology biomarkers and a patient-facing mobile app to monitor symptoms, with a gamification engine for patient engagement. The AI-based technology will provide a continuous quantification of pain by applying analytics to physiology biomarkers. The platform will also include a clinician-facing web dashboard for remote review and intervention.

 

“Through the partnership with Biofourmis, a leading company in research, development and commercialization of digital therapeutics, Chugai will set out to objectively assess pain associated with endometriosis and better understand its pathology,” said Satoko Shisai, Chugai’s Vice President, Head of Digital & IT Supervisory Division. “Through this partnership, Chugai is demonstrating its commitment to applying the most advanced digital technologies to better understand the real-life needs of patients and to develop innovative solutions for society, as outlined in the CHUGAI DIGITAL VISION 2030.”

 

Kuldeep Singh Rajput, CEO and founder of Biofourmis, said: “Chugai aims to become a top innovator by utilizing digital technologies, and we are thrilled to partner with them.” He added: “This unique collaboration with Chugai is another indicator of the growing consensus in the healthcare industry that combining digital solutions with therapeutic developments—from discovery to patient care—is a powerful way to augment efficiency. Digital solutions can deliver faster, more reliable insights to clinicians to aid interventions, while increasing engagement and improving outcomes for patients and lowering healthcare costs for all stakeholders.”

 

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Squid Game

Squid Game and Its Lessons on Entrepreneurship

With the massive media buzz the South Korean series “Squid Game” has been getting, you would have to live under a rock to not know about it. It is so popular that a South Korean broadband firm has sued Netflix over the surge in network traffic.

What Is Biotechnology

What Is Biotechnology and How to Start a Biotech Company?

To say that Covid has been a biological nightmare for the world is an understatement. In a bid to wake up from it, companies and investors have turned their attention to science, medicine and innovation—or simply, biotechnology. With vaccines and cures becoming the need of the hour, BioTech rose like never before.

Netflix

Netflix Forays into Video Games with Night School Studio Acquisition

On September 28, 2021, streaming service Netflix announced its first game-related acquisition: Night School Studio. The studio is best known for its game “Oxenfree”, which is a supernatural teen thriller. In a bid to diversify its offerings, Netflix has also released five mobile-friendly video games in Europe (i.e. Spain, Italy and Poland).

Chloe NFT

Side-eyeing Chloe NFT Sold for US$76,377.50

In 2013, the then two-year-old Chloe Clems went viral as her hilarious side-eyeing expression made her into a beloved internet meme. In her meme avatar, little Chloe has ruled over the hearts of many a Twitter and Reddit enthusiast and has been dubbed the “Patron saint of Tumblr” by Buzzfeed.

What Are the Threats of Using Social Media

What Are the Threats of Using Social Media?

Social media has become a part of our everyday lives. As of September 2021, the largest social media platform Facebook has over 2.89 billion active users monthly. With people across the world relying heavily on social media platforms, it is expected that some of them would exploit these platforms for negative purposes as well.

Maker in China Fueling Hong Kong’s Startup Spirit

Maker in China: Fueling Hong Kong’s Startup Spirit

On September 17, 2021, the “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021 Grand Final was held in Guangzhou, China. MAD Gaze, a Cyberport incubatee specializing in augmented reality smart glasses, was declared the winner of the championship.